Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of inhibitors of ADAM12 as adjuvants in tumor therapies

Use of inhibitors of ADAM12 as adjuvants in tumor therapies

US Patent 11780934 · Granted Oct 10, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ADAM12 inhibitors and their use against inflammation-induced fibrosis2021
ADAM12 inhibitors and their use against inflammation-induced fibrosis2017